Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 25-36 of 75
» View wsbtradio.com items only
    Apr 28, 2008 |Story| Los Angeles Times
  1. Moles' split personality

    We've long been told to keep an eye on our moles lest they progress to melanoma, a form of skin cancer that's treatable if caught early, deadly if not. But not all moles are equal -- some are risky; others can be safely left alone. The biological roots of those differences are not really understood. However, scientists are making progress on several fronts.
    Special to the Los Angeles Times
    We've long been told to keep an eye on our moles lest they progress to melanoma, a form of skin cancer that's treatable if caught early, deadly if not. But not all moles are equal -- some are risky; others can be safely left alone. The biological roots of...

    Tags: Massachusetts General Hospital, Mole (lesion), Michael Green, Boston, Leukemia

  2. Sep 13, 2012 |Story| Los Angeles Times
  3. Fighting diseases with genetic therapy

    Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by prescribing some new snippets of DNA.
    Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by...

    Tags: Colleges and Universities, University of Pennsylvania, Genetic Condition, Health Treatments, Genes and Chromosomes

  4. Mar 19, 2012 |Story| South Florida Sun-Sentinel
  5. Rare diseases affect millions of American families

    One in 10 Americans is currently affected by a rare disease. For these people, getting properly diagnosed and treated can be a challenge.
    www.southfloridaparenting.com
    One in 10 Americans is currently affected by a rare disease. For these people, getting properly diagnosed and treated can be a challenge. Studies have shown it often takes five years or longer to receive an accurate diagnosis of a rare disease, according...

    Tags: Skin Rash, Genes and Chromosomes, Drugs and Medicines, Health, Symptoms

  6. Jun 15, 2012 |Story| Aberdeen News
  7. Novartis introduces Cattle Vaccine Literature Library app for iPads

    Greensboro, N.C. - Novartis Animal Health announces the release of a new app designed specifically for U.S. cattle veterinarians and producers. The Novartis Cattle Vaccine Literature Library app provides fast and convenient access to over 50 product...

    Tags: Computer Hardware, Drugs and Medicines, Vaccines, Arts and Culture, Marketing

  8. Jun 19, 2012 |Story| Hartford Courant
  9. Alexion: Profile From The Company's 2012 Annual Report

    Overview Alexion is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Our marketed product Soliris®...

    Tags: Dialysis, Japan, Litigation and Regulation, Eyes and Vision, Government Health Care

  10. Jan 9, 2012 |Story| WPMT-LTV
  11. Novartis Recalls Popular OTC Medication

    Novartis Consumer Health (NCH) is voluntarily recalling all lots of select bottle sizes of Excedrin® and NoDoz® Alertness Aid products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X® Prevention® products with expiry dates of December 20, 2013 or earlier, in the United States.
    Novartis Consumer Health (NCH) is voluntarily recalling all lots of select bottle sizes of Excedrin® and NoDoz® Alertness Aid products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X® Prevention® products with expiry dates...

    Tags: Consumers, Product Recalls

  12. Jan 10, 2012 |Story| WPIX-LTV
  13. Excedrin, Bufferin Recalled Due to Broken, Mislabeled Pills

    Pharmaceutical company Novartis on Sunday voluntarily recalled a number of over-the-counter drugs -- including certain bottles of Excedrin and Bufferin -- due to complaints about mislabeled and broken pills.
    Pharmaceutical company Novartis on Sunday voluntarily recalled a number of over-the-counter drugs -- including certain bottles of Excedrin and Bufferin -- due to complaints about mislabeled and broken pills. The Switzerland-based company said on its...

    Tags: Drugs and Medicines, Over-the-Counter Medicines, Companies and Corporations, Economy, Business and Finance, Percocet (drug)

  14. Dec 7, 2011 |Story| Petoskey News
  15. Big promise is seen in 2 new breast cancer drugs

    SAN ANTONIO (AP) — Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse. In a large international...

    Tags: Massachusetts General Hospital, Heart Problems, Cancer, Health Treatments, Duke University

  16. Dec 8, 2011 |Story| Petoskey News
  17. Study: Bone drug boosts breast cancer survival

    SAN ANTONIO (AP) — Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: The bone drug...

    Tags: Osteoporosis, Physical Conditions, Cancer, Austria, Health Treatments

  18. Jan 9, 2012 |Column| WXIN-LTV
  19. Novartis issues voluntary recall of over the counter pills

    Pharmaceutical giant Novartis has issued a massive over the counter pill recall.  
    Pharmaceutical giant Novartis has issued a massive over the counter pill recall.   The voluntary recall comes after the company got several customer complaints about mislabeled and broken pills. Certain varieties of Excedrin and Nodoze with December...

    Tags: Companies and Corporations, Economy, Business and Finance

  20. Jan 13, 2012 | Orlando Sentinel
  21. Report: Paula Deen has diabetes

    The Fitness Center - Orlando Sentinel
    Update, 5:44 p.m.: A Novartis spokesperson has contacted the Orlando Sentinel to say that the company is not working with Paula Dean. “The rumors that Novartis has signed a multimillion dollar spokesperson deal with Paula Deen for a diabetes...
  22. Nov 20, 2005 |Story| Los Angeles Times
  23. Take your pills, ignore your belly

    Greg Critser is the author of "Generation Rx: How Prescription Drugs Are Altering American Bodies, Minds and Lives."
    LAST WEEK, stock market analysts parsed the latest sales reports from the nation's biggest drug companies in search of why profits in the normally high-performing industry have plummeted. Good luck finding anything new. Pharma chief executives offer...

    Tags: Cancer, Prescription Drugs, Bristol Myers Squibb Company, Drugs and Medicines, Health

< Previous1 2  3  4 5 6 7Next >
Original site for Novartis AG topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Novartis AG Photos
Barbara Kittridge has been appointed chief marketing of...
(January 10, 2013)
Barbara Kittridge, chief marketing officer, Cardinal Path Inc.
Steve Auten has joined Cozen O'Connor as a member of th...
(September 5, 2012)
Steve Auten, partner, Cozen O'Connor
Since its release on Wednesday, April 4, West's single...
(April 8, 2012)
Kanye vs. Theraflu (2012)